Successful experimental treatment of congenital ichthyosis in an infant
- 6 March 2013
- journal article
- case report
- Published by BMJ in BMJ Case Reports
- Vol. 2013
Abstract
Ichthyosis is a rare genetic disease that causes defects in skin keratinisation. Infants born with this disease have tight shiny skin that inhibits limb and ear mobilities, eyelid and lip deformities and poor hair and nail growths. In addition, the barrier properties of the skin are disrupted, which leads to dehydration, body temperature regulation difficulties and increased susceptibility to infection. The treatments currently available include topical keratolytics, emollients, and for severe disease systemic retinoids. Given the increased permeability of the skin and increased body surface area infants are particularly susceptible to accidental overdose from the topical keratolytic treatments currently available. An experimental emollient of 10%N-acetylcysteine (NAC) and 5% urea was recently used with success in Argentina. A newborn with congenital ichthyosis cared for in our clinic failed his initial treatment of topical emollients. He was subsequently treated successfully with off-label use of a topical 5% NAC and 5% urea emollient.Keywords
This publication has 7 references indexed in Scilit:
- Successful Treatment with Topical N‐Acetylcysteine in Urea in Five Children with Congenital Lamellar IchthyosisPediatric Dermatology, 2011
- Rapid improvement in digital ischemia and acral contracture in a collodion baby treated with topical tazarotene.2010
- Topical N-acetylcysteine treatment in neonatal ichthyosisThe Turkish Journal of Pediatrics, 2003
- IchthyosisAmerican Journal of Clinical Dermatology, 2003
- Topical N-acetylcysteine for lamellar ichthyosisThe Lancet, 1999
- Effect of topical tazarotene in the treatment of congenital ichthyosesBritish Journal of Dermatology, 1999
- Suppression of Fibroblast Cell Cycle Progression in G1 Phase byN-AcetylcysteineToxicology and Applied Pharmacology, 1998